Efficacy of Bisheri Booti in Warm-e-Ghudda-i-Madhi Sulb (BPH)

Efficacy of Bisheri Booti in Warm-e-Ghudda-i-Madhi Sulb-An observational clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011694

Enrollment

Registered

2018-02-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Benign Prostatic Hyperplasia(BPH)

Interventions

Intervention1: Bisheri Booti: Dose,Route of administration & schedule module: 10 gm BD in form of Safuf (powder) orally. Intervention2: Bisheri booti (Aerva lanata): 10 gm BD in form of Safuf (powd

Eligibility

Inclusion criteria

Inclusion criteria: USG findings. Weight upto 60gm RUV IPSS score > 7 P/R findings- reached with difficulty to upper pole of prostate Age 45-70 years.

Exclusion criteria

Exclusion criteria: Patient with severe Cardiac, Pulmonary, Hepatic and Renal disease. Evidence of stricture of urethra. Acute retention of urine PSA >8.0ng/ml

Design outcomes

Primary

Measure	Time frame
Prostate Size Bothersome Index PVR I-PSS Timepoint: During treatment- fortnightly for 45days ( 0,15th ,30th ,45st day) total 45 days	—

Secondary

Measure	Time frame
Fatty liver Urolithiasis EDTimepoint: 45 days	—

Countries

India

Contacts

Public ContactMohd Faisal

NIUM

drfirdous2012@gmail.com7483144988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026